Urispas - Flavoxate
4 customer reviewsUrispas is an oral antispasmodic medicine containing flavoxate. It is for adults with urinary tract irritation causing urgency, frequency, and painful bladder spasms. Flavoxate relaxes smooth muscle in the bladder and urinary tract to reduce cramping and discomfort.
What is it?
Urispas is a medicine used to ease symptoms linked to urinary tract irritation, when the bladder feels “overactive” or spasmodic. People typically look for it when they are struggling with frequent urination, sudden urgent urges, lower abdominal discomfort, or pain during urination.
Common situations where Urispas is used include:
- UTI-related irritation (burning, urgency, frequency) while appropriate antimicrobial treatment is arranged
- Cystitis-type symptoms with bladder cramping
- Urethral irritation with painful spasm
- Prostatitis-related urinary discomfort where spasm contributes to pain
Urispas helps symptoms. It does not sterilise urine or replace antibiotics when a UTI is present. If fever, flank pain, chills, or visible blood in urine are part of the picture, that is a different risk category and needs medical assessment.
Composition
Active ingredient: flavoxate hydrochloride (flavoxatum hydrochloridum). Excipients vary by manufacturer and may include tablet fillers and binders (e.g., lactose or cellulose derivatives), disintegrants, lubricants such as magnesium stearate, and film-coating agents.
How to use?
- Swallow with water.
- Keep doses spaced through the day.
URISPAS 200MG TABLET is used for symptom control, so clinicians often reassess within a few days to confirm the pattern of symptoms still fits an “irritation/spasm” problem rather than something that needs a different approach.
If you miss a dose
Take it when you remember, then continue your normal schedule. Do not double up. Doubling tends to increase dizziness and nausea without improving bladder comfort.
Can I take Urispas with food?
Yes, Urispas can be taken with or without food. If nausea occurs, taking doses after meals often reduces stomach discomfort. Food does not “block” the effect, but it can smooth side effects for sensitive stomachs.
How does it work?
- Route: oral (tablets)
- Dose: 100–200 mg per dose (typical adult dose: 200 mg)
- Frequency: 3–4 times/day
- Timing: take after meals; if drowsiness occurs, avoid taking a dose right before activities requiring alertness
- Duration: use for the shortest period needed, commonly up to 1–2 weeks, or as prescribed; seek review if symptoms persist or worsen
- Maximum daily amount: do not exceed 800 mg/day unless specifically prescribed
Indications
Doctors prescribe Urispas (flavoxate) for the symptomatic relief of painful bladder spasm and lower urinary tract irritation. It is aimed at the discomfort — urgency, increased frequency, dysuria (painful urination), suprapubic pain, and incontinence linked to spasm — rather than at the underlying cause.
It is commonly used as supportive therapy in conditions such as:
- Cystitis, urethritis, and urethrocystitis;
- Prostatitis where spasm adds to the pain;
- Symptom relief during a confirmed urinary tract infection while the prescribed antibiotic does the curative work.
Flavoxate does not treat the infection itself. Red-flag features such as fever, flank pain, chills, or blood in the urine point to a complication that needs separate medical assessment.
Comparison
It can reduce urgency and frequency, but it is not the same as dedicated overactive bladder therapies used long-term. Urispas is often used for short-term symptom relief when irritation and spasm are prominent, including during acute urinary discomfort episodes. Longer-term plans depend on the cause (infection, bladder syndrome, pelvic floor issues, prostate disease).
Contraindications
- Hypersensitivity to flavoxate / Flavoxate Hydrochloride
- Urinary retention due to mechanical obstruction
- Gastrointestinal obstruction
- Active gastrointestinal bleeding
- Closed-angle glaucoma
- Concomitant use with cisapride (combination generally avoided due to safety concerns)
Not recommended for
Do not use Urispas if you have ever had an allergic reaction to it. Avoid it if you cannot empty your bladder properly or have symptoms of urinary retention, such as a weak stream, painful fullness, or being unable to pass urine. It is also not suitable if you have closed-angle glaucoma or a bowel blockage or bleeding, and you should tell your prescriber if you take cisapride or other medicines that make you drowsy, constipated, or very dry.
Side effects
Most side effects are related to antispasmodic activity and tend to be dose-related. Many people get none. Some feel them in the first days.
More common side effects may include:
- Dry mouth
- Nausea or stomach upset
- Headache
- Dizziness, light-headedness
- Blurred vision (mild)
Less common but more serious reactions (seek urgent medical care) may include:
- Allergic reaction (hives, facial swelling, breathing difficulty)
- Severe confusion, severe agitation
- Marked trouble passing urine (acute urinary retention)
Dry mouth is common. Dizziness happens too. Plan your first day sensibly.
Common mistakes
People usually run into trouble from timing, expectations, or missing the bigger diagnosis.
Common mistakes I see:
- Using Urispas as the only treatment for a suspected UTI, then delaying urine testing or antibiotics when they are needed.
- Taking multiple doses close together after a missed dose, then getting dizziness and nausea.
- Ignoring constipation, then stopping the medicine abruptly because they feel “bloated” and assume it is an allergy.
- Continuing despite new urinary retention symptoms (weak stream, painful fullness, inability to pass urine).
Doctor opinions
In clinic, Urispas is often positioned as a “comfort” medicine: it can make the waiting period easier while urine testing, cultures, or a treatment plan is being sorted. Doctors also use it when bladder spasm is a major driver of night-time frequency and sleep disruption.
Frequently asked questions
Yes, Urispas can be taken with or without food. If nausea occurs, taking doses after meals often reduces stomach discomfort. Food does not “block” the effect, but it can smooth side effects for sensitive stomachs.
No. Urispas relieves urinary tract irritation and spasm symptoms, but it does not act as an antibiotic. If a UTI is present, infection-directed treatment is what prevents complications and recurrence. Symptom relief is still useful, because pain and urgency can be intense even early in a UTI.
Yes, it can, especially in people already at risk of incomplete bladder emptying. Warning signs include a weaker stream, increasing lower abdominal pressure, or feeling unable to pass urine despite urgency. If those signs appear, clinicians usually stop the antispasmodic and assess for obstruction or acute retention.
It can reduce urgency and frequency, but it is not the same as dedicated overactive bladder therapies used long-term. Urispas is often used for short-term symptom relief when irritation and spasm are prominent, including during acute urinary discomfort episodes. Longer-term plans depend on the cause (infection, bladder syndrome, pelvic floor issues, prostate disease).
Alcohol can worsen dizziness and sleepiness that some people get with antispasmodics. If you choose to drink, keep the amount low and avoid driving, since the combination makes reaction time less predictable. If alcohol reliably triggers bladder symptoms for you, it may also counteract the benefit you are expecting from Urispas.
Front view
Side view
Back view
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.
Urispas — Comparison with alternatives
Urispas Current Best rated
Prednisone Best price
Ofev
Trusopt
Cytomel
Reviews and Experiences
Sources
- MedlinePlus (2026). Flavoxate: Drug Information. ↑
- MOHAP (Ministry of Health and Prevention) (2026). Guidance for Safe Use of Medicines and When to Seek Urgent Care. ↑
- EMA (European Medicines Agency) (2026). Cisapride: Interaction and Safety Information for Concomitant Medicines. ↑
- World Health Organization (WHO) (2026). WHO Recommendations on Medicines Use in Pregnancy and Breastfeeding. ↑
- EMA (European Medicines Agency) (2026). Flavoxate: Public Summary of Product Characteristics (SmPC) Scientific Framework. ↑